What is NDC 67877-262?

67877-262 is the product NDC for Rizatriptan Benzoate, Rizatriptan benzoate 10 mg/1 tablet, listed with the FDA by Ascend Laboratories, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rizatriptan Benzoate?

56 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rizatriptan Benzoate NDC 67877-262

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-262Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0262Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-262-01	6787702620167877026201	100 TABLET in 1 BOTTLE (67877-262-01)Marketed from Jun 25, 2012
67877-262-05	6787702620567877026205	500 TABLET in 1 BOTTLE (67877-262-05)Marketed from Jun 25, 2012
67877-262-18	6787702621867877026218	3 BLISTER PACK in 1 CARTON (67877-262-18) / 6 TABLET in 1 BLISTER PACKMarketed from Jun 25, 2012
67877-262-25	6787702622567877026225	2 BLISTER PACK in 1 CARTON (67877-262-25) / 6 TABLET in 1 BLISTER PACKMarketed from Jun 25, 2012
67877-262-30	6787702623067877026230	30 TABLET in 1 BOTTLE (67877-262-30)Marketed from Jun 25, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rizatriptan Benzoate
Generic name (nonproprietary): rizatriptan benzoate
Active ingredients: Rizatriptan benzoate — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203269
Marketing start: Jun 25, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 67877-262_9fd3ccaa-ae93-475b-9591-5c4af70f51c5SPL ID 9fd3ccaa-ae93-475b-9591-5c4af70f51c5SPL set ID 07e66554-bc85-4853-9f40-1249617630a9RxCUI 312840, 314209UNII WR978S7QHHUPC 0367877261300
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877026201 followed by a unit qualifier and the quantity

Package 67877-0262-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2022.

Indications (excerpt from the label)

Rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use Rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks. Rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ] . Rizatriptan benzoate tablets are not indicat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-262

What is NDC 67877-262?: 67877-262 is the product NDC for Rizatriptan Benzoate, Rizatriptan benzoate 10 mg/1 tablet, listed with the FDA by Ascend Laboratories, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rizatriptan Benzoate.
What is the active ingredient?: Rizatriptan benzoate.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rizatriptan Benzoate?: 56 other product NDCs are listed under this name. See all Rizatriptan Benzoate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rizatriptan Benzoate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	Tablet, Orally disintegratingOral	Advanced Rx of Tennessee, LLC	80425-0535	80425-0535-01
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	Tablet, Orally disintegratingOral	REMEDYREPACK INC.	70518-4362	70518-4362-00
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	Direct_Rx	72189-512	72189-0512-18
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-447	72189-0447-18
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	Direct Rx	72189-316	72189-0316-18
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	TabletOral	direct rx	72189-258	72189-0258-1272189-0258-18
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	TabletOral	DIRECT RX	61919-656	61919-0656-12
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	DIRECT RX	61919-394	61919-0394-18
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	Tablet, Orally disintegratingOral	Unichem Pharmaceuticals (USA), Inc.	29300-268	29300-0268-2129300-0268-8129300-0268-91
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	Tablet, Orally disintegratingOral	Unichem Pharmaceuticals (USA), Inc.	29300-269	29300-0269-2129300-0269-8129300-0269-91

All 57 Rizatriptan Benzoate NDCs

Other NDCs under ANDA 203269

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203269
Product	Strength	Form · route	Labeler	Product NDC
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	TabletOral	A-S Medication Solutions	50090-3343
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	Ascend Laboratories, LLC	67877-261
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	Bryant Ranch Prepack	71335-2031
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	Bryant Ranch Prepack	71335-2979
Rizatriptan Benzoate	Rizatriptan benzoate 5 mg/1	TabletOral	Direct Rx	72189-316